COPD and Asthma Devices Market

COPD and Asthma Diagnostic and Monitoring Device Market to Reach $8.20 Bn, Globally, by 2027 at 6.3% CAGR: Allied Market Research

PORTLAND, OREGON, UNITED STATES, February 15, 2024 /EINPresswire.com/ -- According to the report published by Allied Market Research, the global COPD And Asthma Diagnostic And Monitoring Device Industry was pegged at $4.95 billion in 2019, and is expected to garner $8.20 billion by 2027, with a CAGR of 6.3% from 2020 to 2027.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/A10567

The global market for COPD and asthma diagnostic and monitoring devices is expected to experience growth due to various factors such as the increasing geriatric population, advancements in diagnostic and monitoring technology, and the rise in respiratory diseases driven by factors like tobacco use, allergens, and air pollutants. Technological innovation plays a significant role in driving market expansion.

According to the World Health Organization, asthma affects approximately 300 million people worldwide, with 250,000 deaths attributed to the condition annually. In 2019, around 65 million people were diagnosed with COPD globally, including 16 million Americans, with numbers expected to rise. Factors such as air pollution, climate change, and allergies further contribute to market growth. Despite these positive trends, challenges such as lack of awareness about these devices, particularly in underdeveloped regions, and stringent regulatory processes may impede market progress.

The global COPD and asthma devices market is segmented according to product, indication, end user, and region. In terms of product, the diagnostic devices segment captured the largest share of revenue, representing over two-thirds of the global asthma diagnostic and monitoring device market in 2019. This segment is anticipated to maintain its leading position through 2027. However, the consumables and accessories segment is forecasted to exhibit the highest compound annual growth rate (CAGR) of 7.4% over the forecast period.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/2187

Regarding indication, the asthma segment dominated the market, holding the majority of revenue share, accounting for nearly two-thirds of the global asthma diagnostic and monitoring device market revenue in 2019. This segment is expected to continue leading through 2027. Conversely, the COPD segment is projected to experience the fastest CAGR of 6.7% from 2020 to 2027.

𝐓𝐡𝐞 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐝𝐨𝐦𝐢𝐧𝐚𝐭𝐞 𝐛𝐲 2027-
Based on product, the diagnostic devices segment contributed to more than two-thirds of the global asthma diagnostic and monitoring device market share in 2019, and is expected to lead the trail by the end of 2027, owing to increase in investment by the giant players and rise in research related funding that gives way to portable devices. The consumables and accessories segment, on the other hand, would grow at the fastest CAGR of 7.4% throughout the forecast period.

𝐊𝐞𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬
Masimo Corporation
Medtronic Plc
Koninklijke Philips N.V
Nihon Kohden Corporation
Smiths Medical
Becton Dickinson And Company
Drägerwerk AG & CO. KGAA
Getinge AB
Invacare Corporation
Vyaire Medical Inc.

𝐒𝐢𝐦𝐢𝐥𝐚𝐫 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
𝐎𝐥𝐢𝐠𝐨𝐧𝐮𝐜𝐥𝐞𝐨𝐭𝐢𝐝𝐞 𝐒𝐲𝐧𝐭𝐡𝐞𝐬𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/oligonucleotide-synthesis-market-A08356
𝐈𝐧𝐟𝐥𝐮𝐞𝐧𝐳𝐚 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 https://www.alliedmarketresearch.com/influenza-treatment-market-A06106

David Correa
Allied Market Research
+ +1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.